Arkansas Children's Hospital is a pediatric hospital with a Level I trauma center in Little Rock, Arkansas. It is among the largest in the United States, serving infants, children, teens, and young adults from birth to age 21.

There are 336 beds in Arkansas Children's Hospital Research Institute.

During the past decade, Arkansas Children's Hospital Research Institute conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 12 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 7 clinical trials were completed. i.e. 46.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arkansas Children's Hospital Research Institute" #1 sponsor was "Arkansas Children's Hospital Research Institute" with 16 trials, followed by "University of Arkansas" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Curemark" with 2 trials sponsored and "Duke University" with 2 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arkansas Children's Hospital Research Institute" #1 collaborator was "University of Arkansas" with 6 trials as a collaborator, "Arkansas Children's Hospital Research Institute" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "St. Christopher's Hospital for Children" with 2 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Arkansas Children's Hospital Research Institute" are "Asthma" (9 trials), "Autism" (5 trials), "Autism Spectrum Disorder" (3 trials), "Autistic Disorder" (3 trials) and "Juvenile Idiopathic Arthritis" (3 trials). Many other conditions were trialed in "Arkansas Children's Hospital Research Institute" in a lesser frequency.

Most popular intervention types in "Arkansas Children's Hospital Research Institute" are "Drug" (28 trials), "Other" (12 trials), "Biological" (4 trials), "Behavioral" (3 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "CM-AT" (2 trials), "Lubiprostone" (2 trials), "Tocilizumab" (2 trials) and "ALS-008176" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arkansas Children's Hospital Research Institute" are 59 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Arkansas Children's Hospital Research Institute". undefined are not yet recruiting, 11 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 34 completed trials in Arkansas Children's Hospital Research Institute, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Arkansas Children's Hospital Research Institute, 7 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 15 trials that are defined as “Not Applicable".